#PointOfCareTesting

[pocdiagnostics]

Revolutionize Bladder Cancer Screening with NADAL NMP22 Test!

Take control of your health with the NADAL NMP22 Test, which is a fast, accurate, and non-invasive solution for early bladder cancer detection.

Benefits of NADAL NMP22: ✔️ Rapid results (~15 mins) ✔️ Easy visual interpretation ✔️ Hygienic, non-invasive urine test ✔️ Ideal for early detection and monitoring

Empower faster decisions. Detect early. Act confidently.

🔗 https://poc-diagnostics.co.uk/products/nadal%C2%AE-nuclear-matrix-protein-22-test 

[wissenresearchllc]

The global market for point of care testing was valued at approximately USD 40.7 billion in 2023, and is projected to increase to USD 40.8 billion in 2025.

[anilchemists]

Anil Chemist Panchkula

⚡ Precision matters in patient care! The I-STAT EG7+ Cartridge is here to revolutionize POC testing. Get rapid and accurate results for electrolytes, blood gases, and more—because every second counts. 🩺✨

Available now at Anil Chemist! 🏥

[market-insider]

Lyme Disease Testing Market Trends and Analysis: Comprehensive Overview of Market Size, Share, Growth

The global lyme disease testing market size is anticipated to reach USD 18.57 billion by 2030 and is projected to grow at a CAGR of 8.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving this market are the increasing prevalence, supportive government policies regarding healthcare facilities, and the introduction of new diagnostic tests for Lyme disease. In addition, the growing incidence of tick-borne diseases further expands the global market. For instance, in August 2022, the U.S. Fair Health Organization reported that Lyme disease has significantly increased in prevalence over the past 15 years, becoming a growing national concern.

Lyme Disease Testing Market Report Highlights

Based on technology, the other segment led the market with the largest revenue share of 88.6% in 2023. The widespread adoption of these tests, considered the gold standard for testing due to their high specificity and sensitivity, significantly contributed to the growth of this segment

Based on testing, the serological test segment led the market with the largest revenue share of 53.1% in 2023. These tests dominated the market as they are widely available, affordable, established, and reliable in detecting antibodies against Borrelia burgdorferi. This makes them a trusted and accessible option for healthcare providers and patients

Based on sample, the blood segment led the market with the largest revenue share of 62.4% in 2023. This is due to the blood tests, such as ELISA and Western blot, which can effectively detect antibodies against Borrelia burgdorferi, the bacteria causing Lyme disease. Blood samples are also easy to obtain and handle, making them a practical choice for widespread diagnostic use

Based on end use, the hospital segment led the market with the largest revenue share of 58.4% in 2023. Firstly, hospitals can access advanced technology and diagnostic tools, enabling accurate & timely testing. The high hospital patient volume, including those with complex and severe symptoms, necessitates reliable diagnostic services, further driving their market dominance

In January 2024, DiaSorin announced that it submitted the LIAISON LymeDetect test to the U.S. FDA in December 2023. Developed in partnership with QIAGEN, this test detects IgG, IgM, and T-cell mediated responses using QIAGEN’s proprietary QuantiFERON technology, an Interferon-Gamma Release Assay (IGRA). This novel solution will enhance DiaSorin's LIAISON immunodiagnostic offerings in the U.S. market, representing a significant milestone in its collaboration with QIAGEN

For More Details or Sample Copy please visit link @: Lyme Disease Testing Market Report

Growing government initiatives and preventive measures significantly drive the market growth. For instance, in July 2022, an article titled "New laws seek to boost funding of Lyme disease research" highlighted that New York officials have increased funding for Lyme disease and tick-borne illnesses through a new law signed by Governor Kathy Hochul. This bipartisan measure will establish a voluntary tax check-off box to support education, research, and prevention efforts related to the disease in the region. Despite the high incidence of Lyme and tick-borne illnesses, it is believed that the actual number of cases is much higher due to inaccurate diagnostic testing.

Heightened awareness and education are further propelling market growth. Public health campaigns to educate communities about prevention strategies and symptoms have become increasingly prevalent. This growing awareness leads to more individuals seeking medical attention when they exhibit symptoms consistent with the disease, thereby driving demand for reliable testing options. Furthermore, educational initiatives targeting healthcare professionals ensure they remain informed about best practices for diagnosis and treatment.

List of major companies in the Lyme Disease Testing Market

DiaSorin S.p.A

BIOMÉRIEUX

Oxford Immunotec

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific, Inc.

T2 Biosystems

IGeneX

Gold Standard Diagnostics

ZEUS Scientific

Trinity Biotech

For Customized reports or Special Pricing please visit @: Lyme Disease Testing Market Analysis Report

We have segmented global lyme disease testing market report based on technology, testing, sample, end-use, and region.

[yashmedica]

The Future of HbA1c Testing: Continuous Monitoring and Home-Based Solutions

Confused about HbA1c testing technology? Explore the latest trends, from HPLC and enzymatic assays to point-of-care testing and home-based solutions. Discover how these advancements empower diabetes management

HbA1c Testing: A Look at Technology Trends Hemoglobin A1c (HbA1c) testing is a crucial tool for diabetes management. It reflects a patient’s average blood sugar control over a 2-3 month period. But with various testing technologies available, navigating this space can be confusing. Let’s delve into some of the most common questions surrounding HbA1c testing technology: 1. Ruling the Roost:…

[lovelypol]

🧪 Serological Testing Market = Big Growth Vibes: $5.2B Forecast for 2034

Serological Testing plays a crucial role in diagnosing infections, monitoring immune responses, and detecting antibodies in the blood. These tests help identify past infections, assess immunity levels, and track vaccine effectiveness. Unlike PCR tests that detect active infections, serology tests analyze the body’s immune response by detecting IgG, IgM, and IgA antibodies. This makes them invaluable for epidemiological studies, understanding disease spread, and guiding public health policies.

To Request Sample Report : https://www.globalinsightservices.com/request-sample/?id=GIS22169 &utm_source=SnehaPatil&utm_medium=Article

Serological testing is widely used for diagnosing viral infections such as COVID-19, HIV, hepatitis, and dengue, as well as autoimmune disorders and allergies. It is also a critical tool in blood transfusion screening and organ transplantation.

With advancements in diagnostic technology, modern serological tests are faster, more accurate, and accessible. Point-of-care serology tests now enable rapid detection, helping healthcare professionals make timely decisions.

As research progresses, serological testing continues to evolve, enhancing disease surveillance and improving healthcare outcomes. Early detection and monitoring through serological tests can save lives and prevent outbreaks. Stay informed, get tested, and protect your health!

🧪💉🔬 #serologicaltesting #antibodytest #immuneresponse #diagnostictesting #medicaldiagnosis #healthcareinnovation #infectiousdiseases #earlydetection #labtesting #medicalresearch #epidemiology #publichealth #preventivemedicine #antibodydetection #covid19testing #hivscreening #hepatitistest #diseasedetection #healthyliving #diagnosticsolutions #pointofcaretesting #serologytest #autoimmunedisorders #allergytesting #bloodscreening #vaccineimmunity #virusdetection #rapidtesting #labscience #microbiology #biotechnology #medtech #precisionmedicine #pathologylab #healthtech #lifesciences #medicalbreakthrough #labtechnician #scientificresearch #pandemicpreparedness #infectioncontrol #publichealthawareness #diseaseprevention #clinicaldiagnostics #globalhealth #medicaltechnology #futureofhealthcare

💙 Know your immunity, stay ahead of infections!

Research Scope:

· Estimates and forecast the overall market size for the total market, across type, application, and region

· Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling

· Identify factors influencing market growth and challenges, opportunities, drivers, and restraints

· Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates

· Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities

About Us:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1–833–761–1700 Website: https://www.globalinsightservices.com/

[gis56]

Veterinary Consumables Market on the Rise – $9.2B by 2034 🐶💊

Veterinary Consumables Market is projected to grow from $4.5 billion in 2024 to $9.2 billion by 2034, at a CAGR of 7.4%. This market includes surgical instruments, wound care products, diagnostic consumables, and anesthesia supplies, supporting veterinary hospitals, clinics, and research facilities.

To Request Sample Report : https://www.globalinsightservices.com/request-sample/?id=GIS22298 &utm_source=SnehaPatil&utm_medium=Article

Market Trends & Key Drivers

Rising Pet Ownership — Increasing adoption of companion animals boosts demand for veterinary services and consumables.

Advancements in Veterinary Medicine — Minimally invasive surgical techniques and precision diagnostics enhance treatment outcomes.

Growth in Livestock Care — Expansion of the dairy and meat industries fuels demand for wound care, surgical tools, and diagnostic kits.

Sustainable and Cost-Effective Solutions — Biodegradable disposables and recyclable veterinary tools are gaining traction.

Point-of-Care Diagnostics — Rapid diagnostic test kits and reagents are witnessing high demand for early disease detection.

Regional Insights

North America dominates, driven by advanced veterinary infrastructure and high pet care spending.

Europe follows, benefiting from stringent animal health regulations and awareness programs.

Asia-Pacific emerges as a fast-growing region, due to rising disposable income and pet adoption trends.

Market Segmentation

Products: Surgical Consumables, Wound Care, Diagnostic Consumables, Anesthesia Consumables, Catheters

Technology: Laser, Ultrasound, Radiography, MRI, Endoscopy

Application: Companion Animals, Livestock, Equine, Zoo Animals, Aquatic Animals

Material Types: Plastic, Metal, Glass, Rubber

Functionality: Single-Use, Multi-Use, Sterile, Non-Sterile

In 2024, market volume reached 320 million units, with an expected rise to 480 million units by 2028. Companion animal consumables dominate (45%), followed by livestock (35%) and equine (20%). Zoetis Inc., Elanco Animal Health, and IDEXX Laboratories are key players, driving product innovation and market expansion.

#veterinaryconsumables #animalhealth #petcare #woundcare #diagnostickits #companionanimals #livestockcare #veterinarydiagnostics #zoetis #elanco #pointofcaretesting #vettech #surgicaltools #veterinaryhospitals #petwellness #animalcare #veterinaryinnovation #medicaldevices #vetmed #petindustry #biodegradablemedical #sustainablehealthcare #veterinarysurgery #animalwelfare #sterileconsumables #equinecare #petdiagnostics #petowners #livestockhealth #farmanimals #clinicaldiagnostics #veterinarysupplies #endoscopy #ultrasound #petwellbeing #zoosanitation #animalhospitals #petrehabilitation #smartdiagnostics

[biotechscientist]

Biodevices are engineered biological or bio-integrated devices that combine biological elements with electronic, mechanical, or chemical components to perform specific functions in healthcare, diagnostics, environmental monitoring, and biotechnology research. These devices leverage biomaterials, microfluidics, biosensors, and biocompatible engineering to detect, analyze, and manipulate biological processes with high precision.

Key Components of Biodevices:

Biosensors – Detect biological molecules using enzymes, antibodies, or nucleic acids.

Microfluidics – Enable the precise manipulation of small fluid volumes for lab-on-a-chip applications.

Biocompatible Materials – Ensure safe integration with biological systems.

Bioelectronics – Interface biological systems with electronic circuits.

Artificial Organs & Implants – Include bioengineered tissues and smart prosthetics.

Wearable Biodevices – Monitor physiological parameters in real time.

Applications of Biodevices:

Medical Diagnostics: Used in point-of-care testing, glucose monitoring, and cancer biomarker detection.

Drug Delivery: Targeted and controlled release of therapeutics using biosensors.

Tissue Engineering: Development of bioartificial tissues and organoids.

Environmental Monitoring: Detect toxins, pollutants, and pathogens in water or air.

Neuroprosthetics: Brain-computer interfaces and bioelectronic implants.

Biodevices are revolutionizing biotechnology by enhancing precision medicine, personalized diagnostics, and sustainable bioengineering solutions.

Biotechnology Scientist Awards

Visit Our Website : http://biotechnologyscientist.com

Contact Us : support@biotechnologyscientist.com

Nomination Link : https://biotechnologyscientist.com/member-submission/?ecategory=Membership&rcategory=Member…

#sciencefather#researchawards#Scientist#Scholar#Researcher #Biodevices #Biosensors #Bioelectronics #Microfluidics #LabOnChip #Biotechnology #BiomedicalEngineering #Biosensing #TissueEngineering #MedicalDevices #WearableTech #SyntheticBiology #Nanobiotechnology #PointOfCareTesting #BioMEMS #SmartImplants #Neuroprosthetics #GeneticEngineering #RegenerativeMedicine #ArtificialOrgans #DrugDelivery #Biofabrication #ExosomeTech #PrecisionMedicine #BiotechInnovation

👉 Don’t forget to like, share, and subscribe for more exciting content!

Get Connected Here: =============

Facebook :  https://www.facebook.com/profile.php?id=61572562140976

Twitter : https://x.com/DiyaLyra34020

Tumblr : https://www.tumblr.com/blog/biotechscientist

Blogger: https://www.blogger.com/u/1/blog/posts/3420909576767698629

Linked in : https://www.linkedin.com/in/biotechnology-scientist-117866349/

Pinterest : https://in.pinterest.com/biotechnologyscientist/

[gis2080]

"The Future is Printed: How Semiconductor Health Diagnostics Will Change Everything (2025-2033)"

Printable Semiconductor Devices for Health Diagnostics Market is revolutionizing healthcare with flexible, cost-effective semiconductor technologies designed for seamless integration into wearable and implantable health monitoring systems. These devices enable real-time, non-invasive diagnostics, paving the way for personalized medicine, continuous health tracking, and early disease detection.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS32660 &utm_source=SnehaPatil&utm_medium=Article

Biosensors lead the market, facilitating real-time monitoring of health conditions, followed by wearable devices, which reflect the rising consumer interest in personal health management. North America dominates, benefiting from robust healthcare infrastructure and high technology adoption, while Europe follows closely with strong regulatory frameworks. The Asia-Pacific region is rapidly advancing, with countries like China and India investing in healthcare modernization.

This market presents lucrative opportunities for stakeholders, emphasizing the importance of strategic investments and collaborations to unlock the full potential of printable semiconductor technology in health diagnostics.

#printablesemiconductors #healthdiagnostics #wearabletech #biosensors #medtechinnovation #flexiblesemiconductors #digitalhealth #personalizedmedicine #smartpatches #remotehealthmonitoring #pointofcaretesting #nanotechnology #labonchip #inkjetprinting #screenprinting #3dprinting #transistors #biosensortechnology #healthtech #smartwearables #cardiovascularmonitoring #neurodiagnostics #cancerdetection #biomedicalengineering #sensorfusion #iothealthcare #advancedmaterials #medicalelectronics #diagnostictechnology #futureofhealthcare #aiinhealthcare

[pocdiagnostics]

Instant Results. Maximum Accuracy. Zero Hassle.

The Abbott SureStep Oral Fluid Test delivers lab‑grade drug screening from a simple saliva swab in minutes, fast, easy, and ultra‑reliable. Because safety & precision matter. 

✅ Why Choose SureStep? • Lab-quality accuracy • Easy oral fluid collection • Results in under 10 minutes • Ideal for workplace & clinical testing

📌 Learn more: https://poc-diagnostics.co.uk/products/abbott-surestep%E2%84%A2-oral-fluid-test-drug-screen-cube 

[pathologylab]

Join #G2M at the Festival of Genomics & Biodata in Excel, London.

📅 : January 29 & 30 - 2025

📌 : ExCel, London

🏪 : Booth No. 143A

🌍 : https://www.genes2me.com/upcoming-events

Visit us to know more about our advanced #NGS Panels, Point-of-care testing solutions and RT-PCR detection #assays.

#thefestivalofgenomicsbiodata #genomicbiodata #excel #london #rtpcr #ngspanels #poct #pointofcare #conference #exhibition #pointofcaretesting

[sensacore]

We Believe that Every Innovation is a Step Towards the Growth of the Country, and we are proud to acknowledge that we have been part of the Technological Advancement Journey of India for over 15 years and continue to do so by Creating Quality Medical Diagnostic Equipments. We wish everyone a Happy National Technology Day!

[techsciresearch]

Global infectious disease testing market is anticipated to grow at CAGR of 8.27% through 2026 to reach USD27.71 billion. Rapid shift from centralized laboratories to decentralized point-of-care testing facilities and increased funding for research on infectious disease diagnostics are driving the growth of the market.

Read more about Global Infectious Disease Testing Market and get answers to all your questions: https://bit.ly/3niaqLY 

[techscimarketresearch]

Global infectious disease testing market is anticipated to grow at CAGR of 8.27% through 2026 to reach USD27.71 billion. Rapid shift from centralized laboratories to decentralized point-of-care testing facilities and increased funding for research on infectious disease diagnostics are driving the growth of the market.

Read more about Global Infectious Disease Testing Market and get answers to all your questions: https://bit.ly/3niaqLY

[yashmedica]

Early Detection of Prediabetes: New HbA1c Assays for Improved Risk Stratification

HbA1c Testing Landscape in 2024. Explore advancements in point-of-care testing, early diabetes detection, CGM integration, and telehealth

HbA1c Testing Landscape (2024) HbA1c testing plays a crucial role in diabetes management by providing a long-term assessment of blood sugar control. This guide explores the HbA1c testing market segmentation, highlighting recent advancements, industry news, and its significance for healthcare professionals. Understanding Market Segmentation The HbA1c testing market can be segmented based on…

[seamaty]

What is POCT test?🧐🧐🧐

What are the advantages of POCT?🧐🧐👇👇👇